Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Aurora A Antikörper

Dieser Anti-Aurora A Antikörper ist ein Maus Monoklonal Antikörper zur Detektion von Aurora A in WB, ELISA, IF und FACS. Geeignet für Human, Ratte und Affe. Dieses Primary Antibody wurde in 2+ Publikationen zitiert.
Produktnummer ABIN965625

Kurzübersicht für Aurora A Antikörper (ABIN965625)

Target

Alle Aurora A (AURKA) Antikörper anzeigen
Aurora A (AURKA) (Aurora Kinase A (AURKA))

Reaktivität

  • 125
  • 75
  • 38
  • 21
  • 18
  • 13
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
Human, Ratte, Affe

Wirt

  • 119
  • 19
  • 1
  • 1
Maus

Klonalität

  • 101
  • 38
Monoklonal

Konjugat

  • 82
  • 9
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Aurora A Antikörper ist unkonjugiert

Applikation

  • 105
  • 47
  • 37
  • 35
  • 23
  • 19
  • 13
  • 11
  • 10
  • 3
  • 2
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF), Flow Cytometry (FACS)

Klon

1F8
  • Aufreinigung

    Ascitic fluid

    Immunogen

    Purified recombinant fragment of human AURKA expressed in E. Coli.

    Isotyp

    IgG1
  • Applikationshinweise

    Western Bloting: 1/500 - 1/2000.
    Immunofluorescence: 1/200 - 1/1000.
    Flow cytometry: 1/200 - 1/400.
    ELISA: Propose dilution 1/10000.
    Not yet tested in other applications.
    Determining optimal working dilutions by titration test.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C
  • De Luca, Brunetto, Asteriti, Giubettini, Lavia, Guarguaglini: "Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity." in: Oncogene, Vol. 27, Issue 51, pp. 6539-49, (2008) (PubMed).

    Veerakumarasivam, Goldstein, Saeb-Parsy, Scott, Warren, Thorne, Mills, Venkitaraman, Neal, Kelly: "AURKA overexpression accompanies dysregulation of DNA-damage response genes in invasive urothelial cell carcinoma." in: Cell cycle (Georgetown, Tex.), Vol. 7, Issue 22, pp. 3525-33, (2008) (PubMed).

  • Target

    Aurora A (AURKA) (Aurora Kinase A (AURKA))

    Andere Bezeichnung

    AURKA

    Hintergrund

    Aurora A plays a role in cell cycle regulation during anaphase and/or telophase, in relation to the function of the centrosome/spindle pole region during chromosome segregation. Aurora A plays a key role during tumor development and progression and is overexpressed in many human cancers including breast, ovarian and colorectal. Aurora A is viewed as a potential target for anticancer drug treatment.
    Tissue specificity: Highly expressed in testis and weakly in skeletal muscle, thymus and spleen. Also highly expressed in colon, ovarian, prostate, neuroblastoma, breast and cervical cancer cell lines.
    Synonyms: AIK, ARK1, AURA, BTAK, STK6,

    Molekulargewicht

    48kDa

    Gen-ID

    6790

    Pathways

    Zellzyklus, Asymmetric Protein Localization
Sie sind hier:
Chat with us!